2018 is unlikely to see a high-profile ballot initiative on drug pricing after court rulings in DC and South Dakota

2018 is unlikely to see a high-profile ballot initiative on drug pricing after court rulings in DC and South Dakota: https://t.co/5G3rIRGwfx

— Lev Facher (@levfacher) July 17, 2018